MetaCap

Cardiol Therapeutics Statistics

NASDAQ: CRDLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.8626-0.0201 (-2.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cardiol Therapeutics by the numbers

Cardiol Therapeutics has a market capitalization of $110.1 million based on 127.69M shares outstanding. With trailing EPS of $-0.24, Cardiol Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.5% below its 50-day average and 33.8% below its 200-day average.

Average daily trading volume is 1.20M shares, or about $1.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CRDL valuation vs. peer median

CRDL compared with the median of 8 peer companies
MetricCRDLPeer medianDifference
Market cap$110.14M$114.65M-4%
Avg. volume1.20M1.32M-9%

Peer median across 8 companies: FATE, ARMP, ENGN, IVVD, MOLN, HUMA, IPHA, CMPX.

Valuation

Price and trading

Previous close
0.8827
Open
0.88
Day range
0.8417 – 0.8952
52-week range
0.8417 – 2.34
52-week change
-11.35%
Beta
—
Volume
552.97K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
110.14M
Forward Pe
-3.68
Eps
-0.24
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.34
Week52 Low
0.84
Avg Volume
1.20M
Shares Outstanding
127.69M
Ma50
1.30
Ma200
1.30
Earnings Date
Nov 12, 2026
Pct From52w High
-63.14%
Pct From52w Low
2.48%

Related